GLP-1 Medications and Metabolic Health
Summary Download PDF Glucagon-like peptide-1 (GLP-1) receptor agonists represent one of the most significant pharmaceutical advances in the treatment of
Resources
Letter to House Ways and Means Hearing on Modernizing Chronic Disease Care
December 3, 2025The Honorable Vern BuchananChairmanSubcommittee on HealthThe House Committee on Ways and Means1139 Longworth HOBWashington D.C. 20515 The Honorable
Coalition for Metabolic Health Comment on Ultra-Processed Foods
The Honorable Robert F. Kennedy, Jr.Secretary of Health and Human Services200 Independence Avenue, SWWashington, DC 20201 The Honorable Brooke L.
Regulatory Comment: Medical Nutrition Therapy
The Honorable Dr. Mehmet Oz Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Baltimore, MD
Reforming the U.S. Dietary Guidelines for Americans (DGA) for a Metabolically Broken Nation: A Call to Action for the Inclusion of a Low-Carbohydrate Diet
Summary Since the DGA launched in 1980, obesity rates have skyrocketed, and metabolic disease is now the norm: over 75%